Vorwarts Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-02-21
Share capital
5 000,00 PLN
Activity description

Vorwarts Pharma manufactures dietary supplements in line with international standards and works with leading European producers. Its portfolio includes Betargin, Mamalac, Artizhel, Epiwell, Lorekt and Flomma, covering support for detox, digestion, liver function, immunity, mucous membranes and sleep. The company also handles marketing, distribution and international activity, and produces branded products in GMP-certified plants.

Registered address
ul. Juliana Konstantego Ordona 5D/4, 01-237 Warszawa, Poland
Website
vorwartspharma.plWebsite active
Email
Email warning
Phone
Social media
Electronic delivery address
AE:PL-15171-34496-CCWVD-26

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 210.14kMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD -254.55kMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 325.82kMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 1.24mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2018-04-07. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Trademarks

Vorwarts Pharma holds 12 active trademarks registered with the Polish Patent Office. 6 applications are pending. 3 marks have expired or were not registered. The first mark was filed in 2020.

MarkProtected until
REVITALOSEJul 2, 2034
FLommaMay 16, 2034
evisioMay 16, 2034
DŻILLA(word)Mar 26, 2034
EPIWELL(word)Mar 20, 2034

Authorized Representatives

Sergii Boiko – President of the Management Board
Roman Prysiazhniuk – Attorney-in-fact

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board is required.

Ownership

OwnerSharesShare valueStake
Mariia Boiko
10$135.0610%
Sergii Boiko (51)
90$1,215.5690%

Sergii Boiko and Mariia Boiko hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Competitors

Name
Support-Pharmasp. z o.o.
Biocomsp. z o.o.
Beauty Care Solutionsp. z o.o.
Wellnesssp. z o.o.
1PFsp. z o.o.
Grzemaartsp. z o.o. + limited partnership
Food SectorP.S.A.
NutrisleP.S.A.
Pharmbiopolsp. z o.o.
Tomapolsp. z o.o.

Change history

DateEvent
2021-06-16PKD change
2020-11-23Address change
2020-11-23PKD change
2018-02-21Entered in the register

FAQ

Last updated: 2026-07-09